Related Experiment Video
Updated: Aug 9, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus
1Department of Pediatrics, Stanford University School of Medicine, Calif.
Insights
Elevated plasma prorenin activity can predict future microvascular complications like retinopathy and nephropathy in young patients with Type I diabetes. This finding helps identify at-risk individuals for early intervention.
Area of Science:
- Endocrinology
- Nephrology
- Ophthalmology
Background:
- Renin, a hormone precursor, is produced by kidney juxtaglomerular cells.
- Elevated plasma prorenin activity is observed in Type I diabetes patients with microvascular complications.
- This study investigated prorenin activity as a predictor of complications in young Type I diabetes patients.
Purpose of the Study:
- To prospectively assess if rising plasma prorenin activity predicts the development of microvascular complications.
- To evaluate plasma prorenin activity as a risk marker in pediatric and adolescent Type I diabetes.
Main Methods:
- Plasma prorenin activity was measured in 135 children and adolescents with Type I diabetes.
- Patients were monitored for retinopathy and albuminuria over a follow-up period.
- Longitudinal measurements of plasma prorenin and urinary albumin were conducted.
Main Results:
- Plasma prorenin activity was significantly higher in patients with retinopathy or albuminuria compared to controls.
- In patients with uncomplicated diabetes, consistently normal prorenin levels were associated with a low incidence of complications.
- High prorenin values preceded the development of retinopathy or albuminuria by at least 18 months in 8 out of 14 patients.
Conclusions:
- Increased plasma prorenin activity is a significant indicator of high risk for retinopathy and nephropathy.
- Plasma prorenin activity can identify young diabetic patients who will develop microvascular complications.
- Prorenin measurement offers a predictive tool for managing diabetic complications.
Background:
Renin, secreted into the blood by the juxtaglomerular cells of the kidneys, is derived from a larger precursor, prorenin. Plasma prorenin activity is increased in patients with insulin-dependent (Type I) diabetes mellitus who have microvascular complications of their disease. We undertook this study to determine prospectively whether rising prorenin activity can predict the development of complications in young patients with Type I diabetes.
Methods And Results:
Plasma prorenin was measured in 135 children and adolescents with Type I diabetes. The mean (+/- SE) plasma prorenin activity among the 32 patients over the age of 10 years who had had uncomplicated diabetes for 0.1 to 5 years was 8.43 +/- 0.58 ng of angiotensin I per liter.second, as compared with 7.06 +/- 0.32 in 37 control subjects of the same age (P less than 0.05). In the 9 patients older than 10 who had retinopathy or overt albuminuria, the mean plasma prorenin activity was 13.09 +/- 1.43 ng of angiotensin I per liter.second (P less than 0.0001). In 34 patients 10 years old or older with uncomplicated diabetes, 3 to 13 measurements of plasma prorenin activity were taken during a follow-up period of 6 to 39 months. Urinary albumin was determined at each visit, and the patients had regular retinal examinations. Only 1 of the 20 patients who had consistently normal plasma prorenin values had overt albuminuria (ratio of urinary albumin to creatinine, greater than 0.017) or retinopathy, whereas one or both of these complications appeared in 8 of the 14 who had at least one high prorenin value. The plasma prorenin value was significantly higher in these eight patients at least 18 months before a complication was found.
Conclusions:
Increased plasma prorenin activity identifies a group of young patients with diabetes who are at high risk for retinopathy or nephropathy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy

